Knockdown of TRPV4 decreases breast cancer cell invasiveness in vitro and lung metastasis in vivo [196], and further investigation revealed that TRPV4 promotes breast cancer metastasis via Ca2+-dependent activation of AKT and downregulation of E-cadherin expression [197]. The gene discussed is AKT1; the disease is breast cancer.